Nikhil Ananth
Principal·F-Prime
Cambridge, MA, United States
Nikhil Ananth is a Principal at F-Prime investing across therapeutics, medical technology, research tools, and life science software and services. Since joining F-Prime in 2019, he has supported investments including Adela, Countable Labs, Ensoma, Galatea Bio, Invetx, Ivenix, Metsera, and Rallybio. Before F-Prime, he was an Associate at Audax Group focused on private equity investments in healthcare and software.
See the rest of Nikhil Ananth's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.